Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Melatonin in the Acute Phase of Stroke as Measured by Interleukin 6 Biomarker

NCT03843008 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT03843008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03843008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Melatonin in the Acute Phase of Stroke as Measured by Interleukin 6 Biomarker
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Withdrawn
Start date
April 30, 2022
Completion date
January 31, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, stroke, acute